Indigo Agriculture opens European headquarters in Basel
Indigo Agriculture is expanding to Europe and has opened headquarters in Basel to this end. The U.S. company offers pioneering technologies for the agricultural sector. BaselArea.swiss supported Indigo in relocating to Basel.
How can the quality of wheat be tested? (img: pixabay)
Indigo is opening offices in Basel, from where the company’s European business will be managed, as was reported in a press release. Heading up the Europe segment is Georg Goeres, who was previously responsible for commercial operations and strategy at Basel agrochemical company Syngenta.
Founded in 2013, the company from Boston develops pioneering technologies for the agricultural sector. These include microbiotechnology for seed treatments, techniques for soil sampling, grain quality testing, remote sensing and analytics as well as a digital marketplace for grain transactions.
Indigo has as its objective to work together with farmers and various interest groups in Europe. The aim is to further optimize the supply chain in farming and offer consumers traceable and nutritious products. In future, Indigo intends to get European farmers on board for Indigo Carbon, a program to accelerate carbon sequestration from agricultural soil. It supplements the Terraton Initiative, a global project to remove one trillion metric tons of carbon dioxide from the Earth’s atmosphere and use it to enrich agricultural soils.
„Indigo is leading the movement towards beneficial agriculture. That makes it the most exciting company I have been a part of in my 25-year career,“ commented Georg Goeres.
BaselArea.swiss supported Indigo in relocating to Basel.
Share this article
You might also be interested in
Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.Read More
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More